The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease-Reference-Cited by-同舟云学术

The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease

Published:2016-05-09 Issue:5 Volume:11 Page:e0155087
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dotterweich Julia,Tower Robert J.,Brandl Andreas,Müller Marc,Hofbauer Lorenz C.,Beilhack Andreas,Ebert Regina,Glüer Claus C.,Tiwari Sanjay,Schütze Norbert,Jakob Franz

Funder

Deutsche Forschungsgemeinschaft

Research grant from the state of Schlewsig-Holstein

European Union ERDF-European Regional Development Fund

Wilhelm Sander-Stiftung

Deutsche Forschergemeinschaft

Interdisciplinary Center for Clinical Research Würzburg

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Multiple myeloma;RA Kyle;Blood,2008

2. Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma;SS Riedel;PloS one,2012

3. The microenvironment in mature B-cell malignancies: a target for new treatment strategies;JA Burger;Blood,2009

4. Multiple myeloma: increasing evidence for a multistep transformation process;M Hallek;Blood,1998

5. Multiple myeloma: present and future;MA Hussein;Current opinion in oncology,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between kisspeptin and bone: Cellular mechanisms, clinical evidence, and future potential;Annals of the New York Academy of Sciences;2024-09-13

2. Gallium-68-Labeled KISS1-54 Peptide for Mapping KISS1 Receptor via PET: Initial Evaluation in Human Tumor Cell Lines and in Tumor-Bearing Mice;Pharmaceuticals;2023-12-27

3. The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model;Scientific Reports;2023-08-28

4. Mesenchymal stem cells modulate IL-17 and IL-9 production induced by Th17-inducing cytokine conditions in autoimmune arthritis: an explorative analysis;Advances in Rheumatology;2023-07-31

5. The Emerging Therapeutic Potential of Kisspeptin and Neurokinin B;Endocrine Reviews;2023-07-20